Benjamin Eckhardt
Benjamin Eckhardt, MD, MS
NYU School of Medicine, Department of Medicine, Division of Infectious Diseases and Immunology - Assistant Professor Medicine
Bellevue Hospital, Department of Medicine, Division of Infectious Diseases and Immunology
MD, Albert Einstein College of Medicine
MS, Clinical Epidemiology and Health Services Research, Cornell University Graduate School of Medical Sciences
BS, Biological and Environmental Engineering, Cornell University
Research Interests
Hepatitis C, HIV, People who inject drugs, Harm reduction
Benjamin Eckhardt received his MD degree from Albert Einstein College of Medicine and  Internal Medicine training at NYU within the Primary Care Program. After completing residency, he worked in Rwanda for Partners In Health/Inshuti Mu Buzima with a clinical appointment at Brigham and Women’s Hospital and Harvard Medical School. He returned to New York to complete his fellowship training in Infectious Diseases at Weill Cornell Medical College while concurrently receiving a MS in Clinical Epidemiology and Health Services Research. He joined the faculty at NYU/Bellevue in 2016 with a clinical focus in HIV and hepatitis management.

Dr. Eckhardt’s research interest focuses on evaluating models of care to facilitate access, engagement, and retention of active injection drug users in HCV treatment and care.
Principal Investigator, HCV – Source Patient Identification and Group Overlap Treatment. Active


Fong C, Mateu-Gelabert P, Ciervo C, Eckhardt B, Aponte-Melendez Y, Kapadia S, Marks K (2021).
Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City
Drug and Alcohol Dependence, 221, 108589. doi: 10.1016/j.drugalcdep.2021.108589. PMCID: PMC8029599.

Kapadia SN, Katzman C, Fong C, Eckhardt BJ, Guarino H, Mateu-Gelabert P (2021).
Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study
Journal of Viral Hepatitis, 28 (2), 326-333. doi: 10.1111/jvh.13437. PMCID: PMC8207521.

Filardo TD, Khan MR, Krawczyk N, Galitzer H, Karmen-Tuohy S, Coffee M, Schaye VE, Eckhardt BJ, Cohen GM (2020).
Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020)
PLoS One, 15 (11), e0242760. doi: 10.1371/journal.pone.0242760. PMCID: PMC7682848.

Katzman C, Mateu-Gelabert P, Kapadia SN, Eckhardt BJ (2019).
Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination
International Journal of Drug Policy, 72, 33-39. doi: 10.1016/j.drugpo.2019.04.003. PMCID: PMC6717536.

Akiyama MJ, Columbus D, MacDonald R, Jordan AO, Schwartz J, Litwin AH, Eckhardt B, Carmody E (2019).
Linkage to hepatitis C care after incarceration in jail: A prospective, single arm clinical trial
BMC Infectious Diseases, 19 (1), 703. doi: 10.1186/s12879-019-4344-1. PMCID: PMC6686449.

Dr. Eckhardt's NYU Langone Profile